Here are five points:
1. The company’s shares rose by 5.8 percent in the last four weeks.
2. In four weeks, Integra LifeSciences outperformed the index by 3.11 percent.
3. The shares were under the S&P 500 by 6.89 percent in the past week.
4. In the past three months, Integra LifeSciences was up 5.12 percent.
5. The year-to-date stock performance checks in at 30.99 percent.
More articles on devices:
InVivo Therapeutics to present at Congress of Neurological Surgeons’ annual meeting: 5 quick facts
Z-Medical, WebOps partner for US launch of pedicle screw system: 4 takeaways
Spinal implant markets in US and Europe to continue growing: 5 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
